Medibase
EN VI JA

VSS data · Tender results

Search VSS drug tender-winning results

Source: quanlythuoc.vss.gov.vn Last synced: 2026-11-12 Latest batch: 2026-11-11 Tender records: 315397

315397 records found. Showing 106601–106650. Unit / total prices in VND.

Drug / ingredient Reg № Unit Unit price Batch
Proalb
Albumin
Strength / route
20% (w/v) · Infusion
Qty
1,000 Chai
Total
718,000,000
Group
N5
Manufacturer
Reliance Life Science Pvt. Ltd. (India)
Province / Facility
Hanoi · 01015
890410176900 Chai 718,000 2026-03-11
Procoralan 5mg
Ivabradin
Strength / route
5mg · Oral
Qty
24,000 Tablet
Total
246,432,000
Group
N1
Manufacturer
Les Laboratoires Servier Industrie (France)
Province / Facility
Hanoi · 01043
300110526124 Tablet 10,268 2026-03-11
Procoralan 5mg
Ivabradine
Strength / route
5mg · Oral
Qty
6,000 Tablet
Total
61,608,000
Group
N1
Manufacturer
Les Laboratoires Servier Industrie (France)
Province / Facility
Hanoi · 01015
300110526124 Tablet 10,268 2026-03-11
Procoralan 7.5mg
Ivabradin (as ivabradin hydrochloride 8.085mg) 7.5mg
Strength / route
7,5mg · Oral
Qty
11,000 Tablet
Total
116,006,000
Group
N1
Manufacturer
Les Laboratoires Servier Industrie (France)
Province / Facility
Lao Cai · 10061
300110526224 Tablet 10,546 2026-03-11
Procoralan 7.5mg
Ivabradin
Strength / route
7,5mg · Oral
Qty
36,000 Tablet
Total
379,656,000
Group
N1
Manufacturer
Les Laboratoires Servier Industrie (France)
Province / Facility
Hanoi · 01043
300110526224 Tablet 10,546 2026-03-11
Procoralan 7.5mg
Ivabradine
Strength / route
7,5mg · Oral
Qty
1,000 Tablet
Total
10,546,000
Group
N1
Manufacturer
Les Laboratoires Servier Industrie (France)
Province / Facility
Hanoi · 01015
300110526224 Tablet 10,546 2026-03-11
Progermila
Bacillus clausii
Strength / route
2x10^9 CFU/5ml · Oral
Qty
1,000 Ampoule
Total
5,460,000
Group
N4
Manufacturer
CPC1 Hanoi Pharmaceutical JSC (Vietnam)
Province / Facility
Hanoi · 01015
893400090623 Ampoule 5,460 2026-03-11
Progesterone 100mg
Progesteron
Strength / route
100mg · Oral
Qty
3,000 Tablet
Total
21,600,000
Group
N1
Manufacturer
Laboratorios Leon Farma S.A. (Spain)
Province / Facility
Hanoi · 01015
840110168300 Tablet 7,200 2026-03-11
Progesterone 200mg
Progesteron
Strength / route
200mg · Oral
Qty
1,500 Tablet
Total
21,000,000
Group
N1
Manufacturer
Laboratorios Leon Farma S.A. (Spain)
Province / Facility
Hanoi · 01015
840110168400 Tablet 14,000 2026-03-11
Progesterone injection BP 25mg
Progesteron
Strength / route
25mg/1ml · Injection
Qty
100 Ampoule
Total
3,100,000
Group
N1
Manufacturer
Panpharma GmbH (Germany)
Province / Facility
Hanoi · 01015
VN-16898-13 Ampoule 31,000 2026-03-11
Prograf 0.5mg
Tacrolimus
Strength / route
0,5mg · Oral
Qty
1,000 Tablet
Total
34,088,000
Group
N1
Manufacturer
Astellas Ireland Co., Ltd. (Ireland)
Province / Facility
Lao Cai · 10061
VN-22057-19 Tablet 34,088 2026-03-11
Prograf 0.5mg
Tacrolimus
Strength / route
0,5mg · Oral
Qty
11,000 Tablet
Total
374,968,000
Group
N1
Manufacturer
Astellas Ireland Co., Ltd. (Ireland)
Province / Facility
Hanoi · 01043
VN-22057-19 Tablet 34,088 2026-03-11
Prograf 1mg
Tacrolimus
Strength / route
1mg · Oral
Qty
1,000 Tablet
Total
51,130,000
Group
N1
Manufacturer
Astellas Ireland Co., Ltd. (Ireland)
Province / Facility
Lao Cai · 10061
VN-22209-19 Tablet 51,130 2026-03-11
Prograf 1mg
Tacrolimus
Strength / route
1mg · Oral
Qty
39,000 Tablet
Total
1,994,070,000
Group
N1
Manufacturer
Astellas Ireland Co., Ltd. (Ireland)
Province / Facility
Hanoi · 01043
VN-22209-19 Tablet 51,130 2026-03-11
Proponex 200
Propofol
Strength / route
10mg · Infusion
Qty
3,000 Vial
Total
62,037,000
Group
N2
Manufacturer
Aspiro Pharma Limited (India)
Province / Facility
Hanoi · 01015
890114432525 Vial 20,679 2026-03-11
Propylthiouracil DWP 100mg
Propylthiouracil
Strength / route
100mg · Oral
Qty
10,000 Tablet
Total
7,350,000
Group
N4
Manufacturer
Wealphar Pharmaceutical JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110286724 Tablet 735 2026-03-11
Prusenza 5 mg
Perindopril
Strength / route
5mg · Oral
Qty
50,000 Tablet
Total
206,850,000
Group
N3
Manufacturer
DRP Inter Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
893110223723 Tablet 4,137 2026-03-11
Prusenza Plus 10/2.5 mg
Perindopril + indapamid
Strength / route
10mg; 2,5mg · Oral
Qty
20,000 Tablet
Total
108,000,000
Group
N4
Manufacturer
DRP Inter Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
893110035124 Tablet 5,400 2026-03-11
Pulmicort Respules
Budesonid
Strength / route
500mcg/2ml · Aerosol inhalation
Qty
30,000 Ampoule
Total
415,020,000
Group
N1
Manufacturer
Astrazeneca Pty., Ltd (Australia)
Province / Facility
Lao Cai · 10061
VN-22715-21 Ampoule 13,834 2026-03-11
Pulmicort Respules
Budesonid
Strength / route
1mg/2ml · Aerosol inhalation
Qty
20,000 Ampoule
Total
498,120,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Lao Cai · 10061
730110131924 Ampoule 24,906 2026-03-11
Pulmicort Respules
Budesonid
Strength / route
500mcg/2ml · Inhalation
Qty
10,000 Ampoule
Total
138,340,000
Group
N1
Manufacturer
Astrazeneca Pty., Ltd (Australia)
Province / Facility
Hanoi · 01015
VN-22715-21 Ampoule 13,834 2026-03-11
Pyfaclor 500mg
Cefaclor
Strength / route
500mg · Oral
Qty
20,000 Tablet
Total
124,000,000
Group
N2
Manufacturer
Pymepharco JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110550624 Tablet 6,200 2026-03-11
Pyzacar HCT 100/12.5mg
Losartan + hydroclorothiazid
Strength / route
12,5mg;100mg · Oral
Qty
50,000 Tablet
Total
99,750,000
Group
N4
Manufacturer
Pymepharco JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110550924 Tablet 1,995 2026-03-11
Pyzacar HCT 100/25mg
Losartan + hydroclorothiazid
Strength / route
100 mg;25 mg · Oral
Qty
50,000 Tablet
Total
94,500,000
Group
N3
Manufacturer
Pymepharco JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110151025 Tablet 1,890 2026-03-11
Quancardio
Dan sam, Tam that, Borneol
Strength / route
3,5mg (17,5mg) + 0,343mg (3,43mg) + 0,2mg · Oral
Qty
30,000 Tablet
Total
14,100,000
Group
N3
Manufacturer
Quang Binh Pharmaceutical JSC (Vietnam)
Province / Facility
Quang Binh · 44001
VD-29091-18 Tablet 470 2026-03-11
Quancardio
Dan sam, Tam that, Borneol
Strength / route
3,5mg (17,5mg) + 0,343mg (3,43mg) + 0,2mg · Oral
Qty
0 Tablet
Total
0
Group
N3
Manufacturer
Quang Binh Pharmaceutical JSC (Vietnam)
Province / Facility
Quang Binh · 44001
893110630824 Tablet 470 2026-03-11
Quetiapin DWP 150 mg
Quetiapin
Strength / route
150mg · Oral
Qty
35,000 Tablet
Total
104,370,000
Group
N4
Manufacturer
Wealphar Pharmaceutical JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110159323 Tablet 2,982 2026-03-11
Quimodex
Moxifloxacin + dexamethason
Strength / route
(0,5% (w/v) + 0,1% (w/v)); 6ml · Ophthalmic
Qty
1,500 Vial
Total
30,000,000
Group
N4
Manufacturer
Traphaco Hung Yen Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
893115316900 Vial 20,000 2026-03-11
Quimoxi
Moxifloxacin
Strength / route
0,5% (kl/tt) ; 6ml · Ophthalmic
Qty
2,500 Vial
Total
50,000,000
Group
N4
Manufacturer
Traphaco Hung Yen Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
893115340523 Vial 20,000 2026-03-11
Quinacar 20
Quinapril
Strength / route
20mg · Oral
Qty
30,000 Tablet
Total
195,000,000
Group
N3
Manufacturer
Pymepharco JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110907124 Tablet 6,500 2026-03-11
RESIDRON
Risedronat
Strength / route
35mg · Oral
Qty
1,000 Tablet
Total
51,950,000
Group
N1
Manufacturer
Pharmathen S.A (Greece)
Province / Facility
Hanoi · 01015
VN-20314-17 Tablet 51,950 2026-03-11
Rabeloc I.V.
Rabeprazol
Strength / route
20mg · Injection
Qty
3,000 Vial
Total
402,000,000
Group
N1
Manufacturer
Cadila Pharmaceuticals Ltd. (India)
Province / Facility
Hanoi · 01015
890110443425 Vial 134,000 2026-03-11
Rafivyr
Entecavir
Strength / route
0,5mg · Oral
Qty
15,000 Tablet
Total
244,500,000
Group
N3
Manufacturer
DRP Inter Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
893114066323 Tablet 16,300 2026-03-11
Ramipril GP
Ramipril
Strength / route
5mg · Oral
Qty
30,000 Tablet
Total
164,430,000
Group
N1
Manufacturer
Farmalabor-Produtos Farmacêuticos, S.A (New name: Medinfar Manufacturing, S.A.) (Portugal)
Province / Facility
Hanoi · 01015
560110037625 Tablet 5,481 2026-03-11
Ramipril GP
Ramipril
Strength / route
2,5mg · Oral
Qty
50,000 Tablet
Total
199,500,000
Group
N1
Manufacturer
Medinfar Manufacturing, S.A. (Portugal)
Province / Facility
Hanoi · 01015
560110080323 Tablet 3,990 2026-03-11
Ramipril-AC 2,5 mg
Ramipril
Strength / route
2,5mg · Oral
Qty
80,000 Tablet
Total
319,200,000
Group
N1
Manufacturer
S.C. AC Helcor S.R.L (Romania)
Province / Facility
Hanoi · 01015
VN-23268-22 Tablet 3,990 2026-03-11
Reamberin
Meglumin natri succinat
Strength / route
6g; 400ml · Infusion
Qty
600 Chai
Total
100,782,600
Group
N5
Manufacturer
Scientific Technological Pharmaceutical Firm “POLYSAN”, Ltd. (Nga)
Province / Facility
Hanoi · 01015
460110356325 Chai 167,971 2026-03-11
Rebamipide 100mg Nippon Chemiphar
Rebamipide
Strength / route
100mg · Oral
Qty
50,000 Tablet
Total
165,000,000
Group
N1
Manufacturer
Nippon Chemiphar Vietnam Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
VD-36246-22 Tablet 3,300 2026-03-11
Recombinant Human Erythropoietin for Injection
Erythropoietin
Strength / route
2000IU · Injection
Qty
500 Vial
Total
72,500,000
Group
N5
Manufacturer
Shanghai Chemo Wanbang Biopharma Co., Ltd (China)
Province / Facility
Hanoi · 01015
690410048325 Vial 145,000 2026-03-11
Regivell
Bupivacain hydroclorid
Strength / route
5mg/ml · Injection
Qty
100 Ampoule
Total
1,950,000
Group
N2
Manufacturer
PT. Novell Pharmaceutical Laboratories (Indonesia)
Province / Facility
Hanoi · 01912
VN-21647-18 Ampoule 19,500 2026-03-11
Remebentin 100
Gabapentin
Strength / route
100mg · Oral
Qty
30,000 Tablet
Total
93,000,000
Group
N1
Manufacturer
Remedica Ltd. (Cyprus)
Province / Facility
Hanoi · 01015
529110424925 Tablet 3,100 2026-03-11
Remeclar 250
Clarithromycin
Strength / route
250mg · Oral
Qty
10,000 Tablet
Total
82,000,000
Group
N1
Manufacturer
Remedica Ltd. (Cyprus)
Province / Facility
Hanoi · 01015
529110769724 Tablet 8,200 2026-03-11
Repaglinid DWP 0,5 mg
Repaglinid
Strength / route
0,5mg · Oral
Qty
50,000 Tablet
Total
49,350,000
Group
N4
Manufacturer
Wealphar Pharmaceutical JSC (Vietnam)
Province / Facility
Hanoi · 01015
893110748024 Tablet 987 2026-03-11
Repaglinide Tablets 0.5 mg
Repaglinid
Strength / route
0,5 mg · Oral
Qty
50,000 Tablet
Total
150,000,000
Group
N2
Manufacturer
USV Private Limited (India)
Province / Facility
Hanoi · 01015
VN-23164-22 Tablet 3,000 2026-03-11
Reumokam
Meloxicam
Strength / route
15mg/1,5ml · Injection
Qty
900 Ampoule
Total
16,425,000
Group
N2
Manufacturer
Farmak JSC (Ukraine)
Province / Facility
Hanoi · 01031
482110442823 Ampoule 18,250 2026-03-11
Reumokam
Meloxicam
Strength / route
15mg/1,5ml · Injection
Qty
2,000 Ampoule
Total
35,900,000
Group
N2
Manufacturer
Farmak JSC (Ukraine)
Province / Facility
Hanoi · 01015
482110442823 Ampoule 17,950 2026-03-11
Revolade 25mg
Eltrombopag
Strength / route
25mg · Oral
Qty
756 Tablet
Total
235,134,900
Group
N1
Manufacturer
Siegfried Barbera, S.L. (Spain)
Province / Facility
Hanoi · 01043
840110351324 Tablet 311,025 2026-03-11
Rhinocort Aqua
Budesonid
Strength / route
64µg (mcg); 0.05ml/ 1 dose xit · Nasal spray
Qty
200 Chai
Total
44,164,200
Group
N1
Manufacturer
McNeil AB (Sweden)
Province / Facility
Hanoi · 01015
730100964124 Chai 220,821 2026-03-11
Ridolip 10
Ezetimibe
Strength / route
10mg · Oral
Qty
100,000 Tablet
Total
400,000,000
Group
N3
Manufacturer
Hasan-Dermapharm Joint Venture Co., Ltd. (Vietnam)
Province / Facility
Hanoi · 01015
893110409824 Tablet 4,000 2026-03-11
Rileptid
Risperidon
Strength / route
2mg · Oral
Qty
500 Tablet
Total
2,000,000
Group
N1
Manufacturer
Egis Pharmaceuticals Private Limited Company (Hungary)
Province / Facility
Hanoi · 01912
VN-16750-13 Tablet 4,000 2026-03-11

Reference data only. Verify directly against the VSS portal before relying on it for tender or commercial decisions.

Services by MTC

Need regulatory support in Vietnam?

Handled by MTC Consulting & Trading Co., Ltd, the team behind Medibase — medibase@mtcorp.vn

About this data

Drug tender results published by Vietnam Social Security (VSS) at quanlythuoc.vss.gov.vn/kqdt. Medibase mirrors and indexes it. Each record is one drug line-item at one healthcare facility in one publication batch. Scope: from 2024 onward.